Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Dr. Lal Pathlabs Financial Results

Dr. Lal PathLabs Ltd. reported its FY26 audited results and recommended a final dividend of INR 4/- per share. The company also announced the 100% acquisition of Shahbazkers Diagnostic Centre for up to INR 20 Crore and the incorporation of a new subsidiary in Dubai to expand its diagnostic services footprint.

Source

NSE filing, NSE: LALPATHLAB. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Dr. Lal Pathlabs Ltd: key numbers

Share price
₹1,922.30
Market cap
₹32,266 Cr
Revenue (annual)
₹2,763 Cr
Net profit (annual)
₹504.8 Cr
P/E (TTM)
59.5×Sector 52.0×
Promoter holding
52.93%-0.26% QoQ
FII holding
18.73%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Dr. Lal Pathlabs Ltd

All →

Other financial results announcements

All →